Clinical trials
Drug Hypersensitivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 11 |
| Unknown status | 8 |
| Terminated | 5 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Montpellier | 8 |
| Chulalongkorn University | 4 |
| Bausch & Lomb Incorporated | 2 |
| Seoul National University Hospital | 2 |
| The University of Hong Kong | 2 |
| University Hospital, Lille | 2 |
| Albany Medical College | 1 |
| Althaia Xarxa Assistencial Universitària de Manresa | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Central Hospital, Nancy, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug Hypersensitivity | 55 |
| Hypersensitivity | 12 |
| Anaphylaxis | 7 |
| Drug Hypersensitivity Syndrome | 4 |
| Drug-Related Side Effects and Adverse Reactions | 4 |
| Hypersensitivity, Immediate | 2 |
| Stevens-Johnson Syndrome | 2 |
| Acute Generalized Exanthematous Pustulosis | 1 |
| Breast Neoplasms | 1 |
| Chronic Urticaria | 1 |
Trials
Showing 26 to 50 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.